dc.contributor.author
Peñuelas Haro, Irene
dc.contributor.author
Espinet, Elisa
dc.date.issued
2024-12-23T15:47:37Z
dc.date.issued
2024-12-23T15:47:37Z
dc.date.issued
2023-07-17
dc.date.issued
2024-12-23T15:47:37Z
dc.identifier
https://hdl.handle.net/2445/217250
dc.description.abstract
How pancreatic cancer cells acquire tumor initiating capacities remains poorly understood. A recent study by Yamazaki et al (2023) uncovers a crucial, targetable role of tyrosine kinase-like orphan receptor (ROR1) in PDAC tumor formation and progression.
dc.format
application/pdf
dc.relation
Reproducció del document publicat a: https://doi.org/10.15252/embj.2023114282
dc.relation
The EMBO Journal, 2023, vol. 42, num.14
dc.relation
https://doi.org/10.15252/embj.2023114282
dc.rights
cc-by (c) Peñuelas-Haro, I. et al., 2023
dc.rights
https://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject
Càncer de pàncrees
dc.subject
Receptors cel·lulars
dc.subject
Cèl·lules canceroses
dc.subject
Diagnòstic molecular
dc.subject
Pancreas cancer
dc.subject
Cell receptors
dc.subject
Molecular diagnosis
dc.title
A novel empeROR of pancreatic malignancy
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
